… of psoralen gathered over recent years. Firstly, multiple studies have demonstrated that psoralen
… In addition, the antitumor properties of psoralen are associated with the induction of ER …

… Acute graft-versus-host disease (aGVHD) is a frequent and major … psoralen and ultraviolet
(UV)-A light have been used in the treatment of chronic cutaneous graft-versus-host disease, …

… treated with PUVA using oral psoralen (5-methoxypsoralen) and a UV-A dosimetry regimen
similar to that used to treat … Eczema-like cutaneous graft versus host disease treated by UV-B …

… Psoralen plus … to treat a variety of immune-mediated dermatologic diseases. We administered
PUVA to 103 patients for treatment of steroid-resistant acute graft-versus-host disease (…

… Patients were treated with psoralen plus ultraviolet (PUVA)-bath photochemotherapy three
times weekly following a standardized treatment protocol under continued treatment with …

… psoralen, a synthetic psoralen, and UVA light as photochemical therapy (PCT) of the T cells.
Psoralens … Long wavelength UVA light induces psoralen to react with pyrimidine and cross-…

… We have reviewed our treatment of 40 patients treated at a single institution with PUVA (ultraviolet
irradiation and psoralen) over a 14 year period. Thirty-five patients were treated for …

… host disease (GVHD) after undergoing a matched, unrelated bone marrow transplant. Her
symptoms worsened despite treatment with … After treatment with tacrolimus and Psoralen plus …

… malignant diseases. A major complication is the induction of graft—versus—host disease. …
reduces the incidence of graft-versus-host disease, the incidence of graft failure often …

… -host disease, resistant to systemic corticosteroid, treated with bath … We analyzed the
graft-versus-host disease clinical … , background diseases, additional treatments, and adverse …